Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NRIX Nurix Therapeutics > Detailed Quotes

NRIX Nurix Therapeutics

Watchlist
12.520
-0.740-5.58%
Close  02/03 16:00 ET
12.5200.0000.00%
Post Mkt Price 02/03 16:04 ET
High
13.280
Open
12.460
Turnover
4.61M
Low
12.460
Pre Close
13.260
Volume
362.31K
Market Cap
590.29M
P/E(TTM)
Loss
52wk High
20.200
Shares
47.15M
P/E(Static)
Loss
52wk Low
7.520
Float Cap
482.97M
Bid/Ask %
-90.48%
Historical High
52.380
Shs Float
38.58M
Volume Ratio
1.36
Historical Low
7.520
Dividend TTM
--
Div Yield TTM
--
P/B
1.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.94%
Amplitude
6.18%
Avg Price
12.732
Lot Size
1
Float Cap
482.97M
Bid/Ask %
-90.48%
Historical High
52.380
Shs Float
38.58M
Volume Ratio
1.36
Historical Low
7.520
Dividend TTM
--
P/B
1.72
Dividend LFY
--
Turnover Ratio
0.94%
Amplitude
6.18%
Avg Price
12.732
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Nurix Therapeutics, Inc. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
CEO: Dr. Arthur T. Sands, M.D.,PhD
Market: NASDAQ
Listing Date: 07/24/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist